Renal Failure Associated with Demeclocycline in Cirrhosis
- 1 August 1977
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 87 (2) , 195-197
- https://doi.org/10.7326/0003-4819-87-2-195
Abstract
Three patients with cirrhosis, ascites, and dilutional hyponatremia were treated with demeclocycline in an attempt to correct the abnormal water retention. Demeclocycline administration (600 to 900 mg/day for 8 to 9 days) resulted in [a] increased blood urea nitrogen and plasma creatinine concentrations; [b] reduction of the inulin clearance by between 63% to 78% and of paraaminohippurate clearance by 36% to 77%; and [c] an impairment of the renal concentrating ability. Urine osmolality decreased to hypotonic levels, but polyuria did not appear, probably because it was prevented by the reduction of the glomerular filtration rate. Renal failure was reversible on withdrawal of demeclocycline. No other causes than demeclocycline administration could be found to explain the reduction of the glomerular filtration rate and the estimated renal plasma flow.Keywords
This publication has 5 references indexed in Scilit:
- Demeclocycline Treatment of Water Retention in CirrhosisAnnals of Internal Medicine, 1976
- Demeclocycline Treatment in the Syndrome of Inappropriate Antidiuretic Hormone SecretionAnnals of Internal Medicine, 1975
- Demeclocycline-Induced Nephrogenic Diabetes InsipidusAnnals of Internal Medicine, 1973
- Reversible "Fanconi Syndrome" Caused by Degraded TetracyclineJAMA, 1963
- Renal Disease and the Metabolic Effects of TetracyclineAnnals of Internal Medicine, 1963